Agilent Technologies Files 8-K Report
Ticker: A · Form: 8-K · Filed: 2024-09-03T00:00:00.000Z
Sentiment: neutral
Topics: sec-filing, 8-k
Related Tickers: A
TL;DR
AGILENT filed an 8-K, likely routine updates, check for details.
AI Summary
On September 3, 2024, Agilent Technologies, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific financial figures or new material events were detailed in the provided text, suggesting it may be a routine filing or an update to previously disclosed information.
Why It Matters
This filing indicates Agilent Technologies is providing updates to the SEC, which could contain important information for investors regarding the company's operations or financial status.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing notification without specific material events or financial disclosures that would immediately indicate high risk.
Key Players & Entities
- AGILENT TECHNOLOGIES, INC. (company) — Registrant
- September 3, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-15405 (identifier) — Commission File Number
- 77-0518772 (identifier) — IRS Employer Identification No.
- 5301 Stevens Creek Boulevard (address) — Principal Executive Offices
- Santa Clara (location) — City of Principal Executive Offices
- CA (state) — State of Principal Executive Offices
- 95051 (zip_code) — Zip Code of Principal Executive Offices
- (800) 227-9770 (phone_number) — Registrant's telephone number
FAQ
What specific "Other Events" are being reported by Agilent Technologies on September 3, 2024?
The provided text of the 8-K filing does not specify the details of the "Other Events" beyond listing it as an item information category.
Are there any new financial statements or exhibits being filed with this 8-K report?
The filing lists "Financial Statements and Exhibits" as an item information category, indicating that such documents are part of the filing, but their specific content is not detailed in the provided text.
What is the primary purpose of this 8-K filing for Agilent Technologies?
This 8-K filing serves as a current report to the SEC, primarily covering "Other Events" and "Financial Statements and Exhibits" as of September 3, 2024.
What is Agilent Technologies' principal executive office address?
Agilent Technologies' principal executive offices are located at 5301 Stevens Creek Boulevard, Santa Clara, CA 95051.
When was Agilent Technologies, Inc. incorporated?
Agilent Technologies, Inc. was incorporated in Delaware, as indicated by the filing.
From the Filing
0001090872-24-000036.txt : 20240903 0001090872-24-000036.hdr.sgml : 20240903 20240903084621 ACCESSION NUMBER: 0001090872-24-000036 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 129 CONFORMED PERIOD OF REPORT: 20240903 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240903 DATE AS OF CHANGE: 20240903 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AGILENT TECHNOLOGIES, INC. CENTRAL INDEX KEY: 0001090872 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 770518772 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15405 FILM NUMBER: 241272258 BUSINESS ADDRESS: STREET 1: 5301 STEVENS CREEK BLVD CITY: SANTA CLARA STATE: CA ZIP: 95051 BUSINESS PHONE: (408) 345-8886 MAIL ADDRESS: STREET 1: 5301 STEVENS CREEK BLVD, MS 1A-LC STREET 2: P.O. BOX 58059 CITY: SANTA CLARA STATE: CA ZIP: 95052-8059 FORMER COMPANY: FORMER CONFORMED NAME: AGILENT TECHNOLOGIES INC DATE OF NAME CHANGE: 19990816 FORMER COMPANY: FORMER CONFORMED NAME: HP MEASUREMENT INC DATE OF NAME CHANGE: 19990716 8-K 1 a-20240903_d2.htm 8-K a-20240903_d2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): September 3, 2024   AGILENT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter)   Delaware 001-15405 77-0518772 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.)   5301 Stevens Creek Boulevard , Santa Clara , CA 95051 (Address of Principal Executive Offices) (Zip Code)   Registrant’s telephone number, including area code (800) 227-9770   (Former name or former address, if changed since last report.)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: TITLE OF EACH CLASS TRADING SYMBOL(S) NAME OF EACH EXCHANGE ON WHICH REGISTERED COMMON STOCK, $0.01 PAR VALUE A New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐   Item 8.01.              Other Events   Agilent Technologies, Inc. (the "Company") is filing this Current Report on Form 8-K for the purpose of incorporating by reference the contents of this report in our filings under the Securities Act of 1933, as amended. Segment Reporting Changes As disclosed in the first quarter of fiscal year 2024, we announced a change in our operating segments to move our cell analysis business from our life sciences and applied markets segment to our diagnostics and genomics operating segment in order to further strengthen growth opport